Inventor · disambiguated record
David Joseph Guerin
Also filed as: GUERIN DAVID · GUERIN DAVID J · GUERIN DAVID JOSEPH
27 granted patents·6 pending applications·146 citations·filing 2005–2024
95Inventor score
Files withMERCK SHARP & DOHME7VALO EARLY DISCOVERY INC4FORMA THERAPEUTICS INC3VALO HEALTH INC3VERTEX PHARMA3
Top patents by PatentIndex Score
33 records- 0196US9902728B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Feb 27, 2018·24 cites·40 claims
- 0295US10934299B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Mar 2, 2021·7 cites·20 claims
- 0395US10377760B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·17 cites·20 claims
- 0494US7381827B2Processes and intermediatesVERTEX PHARMA·Filed 2005·Granted Jun 3, 2008·22 cites·18 claims
- 0592US8551984B2Aminopyrimidines as SYK inhibitorsALTMAN MICHAEL D·Filed 2010·Granted Oct 8, 2013·25 cites·40 claims
- 0691US9242984B2Pyrazolyl derivatives as Syk inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jan 26, 2016·12 cites·21 claims
- 0783US10889592B2Thienopyrazine carboxamides as ubiquitin-specific protease inhibitorsVALO EARLY DISCOVERY INC·Filed 2017·Granted Jan 12, 2021·2 cites·28 claims
- 0883US7834200B2Processes and intermediatesVERTEX PHARMA·Filed 2008·Granted Nov 16, 2010·4 cites·6 claims
- 0983US7550478B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2006·Granted Jun 23, 2009·7 cites·9 claims
- 1082US11524966B1Carboxamides as ubiquitin-specific protease inhibitorsVALO EARLY DISCOVERY INC·Filed 2018·Granted Dec 13, 2022·2 cites·15 claims
- 1181US9023865B2Compounds that are ERK inhibitorsLIM JONGWON·Filed 2012·Granted May 5, 2015·4 cites·20 claims
- 1280US10913753B2Thienopyridine carboxamides as ubiquitin-specific protease inhibitorsFORMA THERAPEUTICS INC·Filed 2017·Granted Feb 9, 2021·2 cites·20 claims
- 1378US12043607B2HDAC inhibitors and therapeutic use thereofTANGO THERAPEUTICS INC·Filed 2022·Granted Jul 23, 2024·0 cites·34 claims
- 1478US8293929B2Processes and intermediatesTANOURY GERALD J·Filed 2010·Granted Oct 23, 2012·3 cites·6 claims
- 1575US2025136570A1Hdac inhibitors and therapeutic use thereofTANGO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1673US9884048B2ERK inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Feb 6, 2018·2 cites·6 claims
- 1772US12018030B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsVALO HEALTH INC·Filed 2021·Granted Jun 25, 2024·0 cites·16 claims
- 1871US9725445B2Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 8, 2017·2 cites·17 claims
- 1971US8183245B2Pyrazine substituted pyrrolopyridines as inhibitors of JAK and PDK1GUERIN DAVID J·Filed 2008·Granted May 22, 2012·9 cites·8 claims
- 2066US9957264B2Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·1 cites·9 claims
- 2162US11325917B2Thienopyrazine carboxamides as ubiquitin-specific protease inhibitorsVALO HEALTH INC·Filed 2020·Granted May 10, 2022·0 cites·20 claims
- 2262US8329722B2Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1SIU TONY·Filed 2008·Granted Dec 11, 2012·1 cites·9 claims
- 2358US2013066083A1Processes and intermediatesVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2457US12252490B2Inhibiting deubiquitinase USP25 and USP28VALO HEALTH INC·Filed 2019·Granted Mar 18, 2025·0 cites·15 claims
- 2557US2024246946A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2656US2014243290A1Aminopyrimidines as SYK InhibitorsALTMAN MICHAEL D·Filed 2014·Application pending·0 cites
- 2750US12162888B2Carboxamides as ubiquitin-specific protease inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Dec 10, 2024·0 cites·15 claims
- 2843US10059705B2Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 28, 2018·0 cites·7 claims
- 2943US9957265B2N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·0 cites·11 claims
- 3043US2009149467A1Tyrosine Kinase InhibitorsMERCK & CO INC·Filed 2006·Application pending·0 cites
- 3139US10072025B2Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Sep 11, 2018·0 cites·17 claims
- 3237US8937077B2Bicyclic diamines as janus kinase inhibitorsGUERIN DAVID JOSEPH·Filed 2011·Granted Jan 20, 2015·0 cites·14 claims
- 3331US2012264735A1Tyrosine kinase inhibitorsYOUNG JONATHAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Joseph Guerin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →